TGFB1 and hepatocellular carcinoma: However, none of the current phase I-II trials in advanced HCC (Table 2) or the ongoing phase III trials focus on TGF-β signaling, despite data from prior studies showing promising results of TGF-β modulation in HCC as previously mentioned.